Home » Stocks » NTRB

Nutriband Inc. (NTRB)

Stock Price: $20.99 USD -0.01 (-0.05%)
Updated Apr 16, 2021 2:50 PM EDT - Market closed
Market Cap 133.42M
Revenue (ttm) 943,702
Net Income (ttm) -2.93M
Shares Out 6.36M
EPS (ttm) -0.51
PE Ratio n/a
Forward PE 526.32
Dividend n/a
Dividend Yield n/a
Trading Day April 16
Last Price $20.99
Previous Close $21.00
Change ($) -0.01
Change (%) -0.05%
Day's Open 21.00
Day's Range 20.99 - 21.00
Day's Volume 315
52-Week Range 3.00 - 32.00

News

There are no news available yet.

About NTRB

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain. Its product line consists of an energy patch line; a weight management patch line; a multivitamin patch line; a children's multivitamin patch line; an amino acid patch line; an anti-wrinkle patch line; an insect repellant patch line; a detox patch line; a PMS... [Read more...]

Industry
Biotechnology
Stock Exchange
OTCMKTS
Ticker Symbol
NTRB
Full Company Profile

Financial Performance

In 2020, Nutriband's revenue was $943,702, an increase of 154.61% compared to the previous year's $370,647. Losses were -$2.93 million, 7.76% more than in 2019.

Financial Statements

Analyst Forecasts

The average 12-month stock price forecast for Nutriband is 24.00, which is an increase of 14.34% from the latest price.

Price Target
$24.00
(14.34% upside)